HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Moderna, Inc. (MRNA) Investors of Ongoing Investigation into Possible Securities Fraud and Insider Trading, Encourages Investors with Significant Losses to Contact Firm

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access